fbpx mmnews


Two Pfizer jabs give 70pc protection from Omicron: South African study

Two shots of Pfizer’s Covid vaccine offers around 70 percent protection against severe disease from Omicron, according to results of a study published Tuesday in South Africa. The emergence of the highly mutated variant, first detected in South Africa last

Pfizer COVID-19 vaccine may only partially protect against Omicron: study

The Omicron variant of the coronavirus can partially evade the protection from two doses of Pfizer and partner BioNTech’s COVID-19 vaccine, the research head of a laboratory at the Africa Health Research Institute in South Africa said on Wednesday. Still,

Sindh receives over 300,000 doses of Pfizer vaccine donated by US

KARACHI: The government of Sindh on Monday received over 300,000 new Pfizer vaccine doses sent by the United States through the COVAX facility. US Consul General Mark Stroh and Sindh Minister of Health and Population Welfare, Dr Azra Fazal Pechuho

Pakistan receives 14,000 doses of Pfizer vaccine

ISLAMABAD: Pakistan has reportedly received new doses of US pharmaceutical company Pfizer’s coronavirus vaccines. According to reports, around 14,000 doses of the vaccine arrived at the Islamabad International Airport aboard a foreign airline. The vaccine was stored in ultra-cold chain

Pakistan to receive 13mn doses of Pfizer vaccine: SAPM

ISLAMABAD: Pakistan has made an agreement to procure 13 million doses of COVID-19 vaccine from Pfizer, said Special Assistant on National Health Services Faisal Sultan. An exact timeline was not yet available, Faisal Sultan told a news agency, but said

US to donate 500 million Pfizer vaccine doses globally

WASHINGTON: The Biden administration plans to donate 500 million Pfizer coronavirus vaccine doses to nearly 100 countries over the next two years The United States is likely to distribute 200 million shots this year and another 300 million in the

EU approves Pfizer-BioNTech COVID-19 vaccine for adolescents

BRUSSELS: The European Commission has authorised Pfizer and partner BioNTech’s COVID-19 vaccine for use in children as young as 12, paving the way for a broader rollout in the bloc after similar clearances in the United States and Canada. The

Pfizer’s COVID-19 vaccine can be refrigerated for a month

WASHINTON: The US Food and Drug Administration has authorised the storage of Pfizer and German partner BioNTech COVID-19 vaccine at standard freezer temperatures for up to one month, in an effort to make the vaccine more widely available. Unopened, thawed

Pfizer sees COVID-19 vaccine demand for years, $26bn in sales

NEW YORK: Pfizer raised its forecast for COVID-19 vaccine sales by more than 70% to $26 billion in 2021, and said demand from governments around the world could contribute to its growth for years to come. The company said it

Pfizer seeks vaccine authorisation for 12-15 year olds in US

WASHINGTON: Pfizer-BioNTech asked for authorization ro use their COVID-19 vaccine on 12 to 15-year-olds in the United States, which could mark a crucial next step toward achieving herd immunity. The companies said in a statement that they plan to make

Pfizer-BioNTech COVID-19 vaccine 91% effective in updated data

WASHINGTON: Pfizer and BioNTech said their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months. The shot also showed early signs of preventing disease in a small subset

Pfizer begins early-stage study for oral COVID-19 drug

WASHINGTON: Pfizer has started an early-stage trial of an oral COVID-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said. The drugmaker, which developed the first authorized COVID-19 vaccine in the US

US approves storing Pfizer COVID-19 vaccine at normal freezer temperature

WASHINGTON: Frozen vials of Pfizer’s COVID-19 vaccine may be stored at temperatures commonly found in pharmaceutical freezers for a period of up to two weeks, the US Food and Drug Administration said. The move loosens a previous requirement that the

Pfizer vaccine effective in reducing transmission of coronavirus: Study

The data from Israel has claimed that the coronavirus vaccine developed by Pfizer and BioNTech appears to be very effective in limiting the spread of COVID-19. A study by Pfizer and the Israeli Ministry of Health showed that the coronavirus

23 elderly patients die in Norway after receiving Pfizer’s COVID-19 vaccine

OSLO: Twenty-three elderly patients died in Norway within days of receiving their first dose of the Pfizer-BioNTech COVID-19 vaccine, prompting a detailed investigation into the fatalities. At least 13 of those deaths were nursing home patients and at least 80

BioNTech boosts vaccine supply forecast to two billion doses in 2021

BERLIN: German company BioNTech, which developed the first coronavirus vaccine approved in the West, said it expects to produce two billion doses in 2021, up from the 1.3 billion previously forecast. “We now believe that we can potentially deliver approximately

WHO grants ’emergency validation’ to Pfizer-BioNTech vaccine

GENEVA: The World Health Organization granted emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution. Britain launched its inoculation drive with the US-German vaccine on December 8, followed by the

US purchases additional 100m doses of Pfizer’s vaccine

WASHINGTON: The United States has purchased an additional 100 million doses of the Pfizer/BioNTech vaccine against COVID-19, with the shots set to be delivered by July, the Pentagon announced. That brings the current US supply of Covid-19 vaccine to 400

EU approves first coronavirus vaccine

BRUSSELS: The European Union finally gave the green light for the Pfizer-BioNTech coronavirus vaccine, paving the way for the first inoculations to start across 27 countries just days after Christmas. The decision was rushed through under pressure from European governments

Swiss authorise Pfizer-BioNTech COVID-19 vaccine

BASELL: Switzerland has approved the use of the Pfizer-BioNTech vaccine, with immunisation set to start just after Christmas as the country battles rising coronavirus cases. The Swissmedic regulatory authority said it had given the green light following a two-month review.

Global COVID-19 cases surpass 75 million

WASHINGTON: Global coronavirus infections surpassed the 75 million mark on Saturday as several nations around the world begin vaccinating against the virus. Britain became the first Western country to start immunizing with the COVID-19 vaccine developed by Pfizer and its

US approves Pfizer-BioNTech COVID-19 vaccine

WASHINGTON: The United States has approved the Pfizer-BioNTech Covid-19 vaccine, paving the way for its imminent rollout across the country, President Donald Trump promising the first immunizations would take place “in less than 24 hours.” “I am authorizing the emergency

Britain to roll-out Pfizer’s COVID-19 vaccine this week

LONDON: Britain is preparing to become the first country to roll out the Pfizer/BioNTech COVID-19 vaccine this week, initially making the shot available at hospitals before distributing stocks to clinics. The first doses are set to be administered on Tuesday,

Britains becomes first country to approve Pfizer’s COVID-19 vaccine

LONDON: Britain had become the first country in the world to approve the Pfizer-BioNTech COVID-19 vaccine for use which will be rolled out from early next week. The vaccine is seen as the best chance for the world to get

Israel signs agreement with Pfizer for coronavirus vaccine

TEL AVIV: US company Pfizer has signed an agreement with Israel to develop a vaccine against the coronavirus, which has been declared a global pandemic.  Under the agreement, Pfizer will provide its own vaccine after going through all stages of

Pfizer CEO sold $5.6 million in stock on day of vaccine announcement

WASHINGTON: Pfizer CEO Albert Bourla sold $5.6 million of his stock in the US pharmaceutical company on the same day it announced promising results for its COVID-19 vaccine. The company has reportedly said the sale was part of a pre-arranged

Vaccine optimism

The world is weary of the coronavirus pandemic which has killed over a million people and decimated economies globally. With a second wave of infections and many countries slipping back into a lockdown, the news of a potentially effective vaccine

Pfizer’s COVID-19 vaccine not suitable for Pakistan: Dr Atta-ur-Rehman

ISLAMABAD: Chairman of Prime Minister’s Task Force on Science and Technology Atta-ur-Rahman has claimed that the Pfizer vaccine being hailed worldwide is not suitable for Pakistan. According to Dr Atta-ur-Rahman, in his opinion, the vaccine is not suitable for Pakistan.